Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The relation of receptor-binding studies to receptor function.

N J Birdsall

    European Journal of Respiratory Diseases. Supplement
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Multiple allosteric sites on muscarinic receptors.

    Life sciences·2001
    Same author

    Agonist binding and function at the human alpha(2A)-adrenoceptor: allosteric modulation by amilorides.

    Molecular pharmacology·2000
    Same author

    Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site.

    Molecular pharmacology·2000
    Same author

    Allosteric interactions between the antagonist prazosin and amiloride analogs at the human alpha(1A)-adrenergic receptor.

    Molecular pharmacology·2000
    Same author

    Effects of contamination on radioligand binding parameters.

    Trends in pharmacological sciences·2000
    Same author

    Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.

    Molecular pharmacology·1999
    Same journal

    An animal model of allergic alveolitis.

    European journal of respiratory diseases. Supplement·1987
    Same journal

    Prevalence of allergic symptoms in rural and urban populations.

    European journal of respiratory diseases. Supplement·1987
    Same journal

    Role of environment in the development of chronic bronchitis.

    European journal of respiratory diseases. Supplement·1987
    Same journal

    Incidence of clinically confirmed farmer's lung in Finland and its relation to meteorological factors.

    European journal of respiratory diseases. Supplement·1987
    Same journal

    Prevalence and incidence of chronic bronchitis and farmer's lung with respect to the geographical location of the farm and to the work of farmers.

    European journal of respiratory diseases. Supplement·1987
    Same journal

    Prevalence and incidence of chronic bronchitis and farmer's lung with respect to socioeconomic factors.

    European journal of respiratory diseases. Supplement·1987
    See all related articles

    Binding assays provide drug-receptor interaction data. Validating these assays requires matching in vitro binding to whole tissue pharmacology, especially for complex agonist interactions.

    Area of Science:

    • Pharmacology
    • Biochemistry
    • Molecular Biology

    Background:

    • Binding studies are crucial for understanding drug-receptor interactions.
    • Assay validity depends on correlating in vitro findings with whole tissue pharmacology.
    • Agonist binding is often more complex than antagonist binding due to receptor-effector coupling.

    Purpose of the Study:

    • To outline the principles and applications of drug-receptor binding studies.
    • To emphasize the importance of validating binding assay conditions.
    • To discuss the complexities of agonist binding and allosteric modulation.

    Main Methods:

    • In vitro binding assays.
    • Comparison with whole tissue pharmacology.
    • Analysis of allosteric modulation.

    Related Experiment Videos

  • Quantification of receptor-binding sites.
  • Main Results:

    • Binding studies offer direct insights into drug-receptor interactions.
    • Agonist binding complexity can be attributed to receptor-effector coupling.
    • Allosteric modulation reveals ligand interactions with effectors.
    • Binding assays can determine receptor-binding site numbers, unlike tissue pharmacology.

    Conclusions:

    • Binding assay validity is established by correlating in vitro and in vivo data.
    • Agonist binding studies require careful consideration of receptor-effector coupling.
    • Allosteric modulation provides a mechanism to study receptor-effector interactions.
    • Quantifying receptor-binding sites offers valuable information on biological system perturbations, though caution is needed in equating these with functional receptors.